5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.85▼ | 4.88▼ | 4.96▼ | 5.11▼ | 6.43▼ |
MA10 | 5.01▼ | 5.08▼ | 5.15▼ | 5.35▼ | 6.89▼ |
MA20 | 5.17▼ | 5.20▼ | 5.24▼ | 6.40▼ | 10.29▼ |
MA50 | 5.38▼ | 5.53▼ | 6.04▼ | 7.35▼ | 15.84▼ |
MA100 | 6.23▼ | 6.82▼ | 7.29▼ | 10.70▼ | 36.67▼ |
MA200 | 7.32▼ | 7.75▼ | 7.97▼ | 15.03▼ | 64.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.035▼ | -0.023▼ | 0.000▲ | -0.111▼ | 0.046▲ |
RSI | 26.405▼ | 25.997▼ | 23.930▼ | 29.580▼ | 34.410▼ |
STOCH | 5.620▼ | 4.477▼ | 20.373 | 15.297▼ | 15.113▼ |
WILL %R | -87.288▼ | -87.288▼ | -87.903▼ | -97.895▼ | -99.474▼ |
CCI | -94.719 | -106.386▼ | -147.898▼ | -120.211▼ | -126.547▼ |
Friday, June 20, 2025 04:07 AM
Investing.com - HCW Biologics (NASDAQ: HCWB) reported third quarter EPS of $-0.14, $0.01 worse than the analyst estimate of ...
|
Wednesday, June 04, 2025 05:31 AM
About HCW Biologics: HCW Biologics Inc. (NASDAQ: HCWB) is a clinical-stage biopharmaceutical company developing proprietary immunotherapies to treat diseases promoted by chronic inflammation ...
|
Tuesday, June 03, 2025 05:00 PM
MIRAMAR, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
20/06/25 | 4.81 | 5.15 | 4.50 | 4.57 | 45,382 |
18/06/25 | 5.12 | 5.15 | 4.81 | 4.86 | 64,681 |
17/06/25 | 5.25 | 5.3677 | 4.62 | 5.30 | 108,858 |
16/06/25 | 5.34 | 5.555 | 5.25 | 5.35 | 38,062 |
13/06/25 | 5.33 | 5.60 | 5.20 | 5.45 | 44,788 |
12/06/25 | 5.16 | 5.77 | 5.16 | 5.50 | 54,643 |
11/06/25 | 5.33 | 5.48 | 5.20 | 5.22 | 23,304 |
10/06/25 | 5.80 | 5.80 | 5.62 | 5.625 | 18,592 |
09/06/25 | 5.87 | 6.15 | 5.58 | 5.58 | 32,486 |
06/06/25 | 5.70 | 6.205 | 5.70 | 6.04 | 26,390 |
|
|
||||
|
|
||||
|
|